Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3763 3771 3783
This examiner grants 78% of resolved cases
Dung T. Ulsh works in Tech Center 3700 and Art Unit 3763, with 385 resolved cases. The examiner's allowance rate is 78.4%, and the median days to allowance is 1081. The interview lift is 17.4%, showing that interviews are a beneficial tactic for increasing the likelihood of a grant.
With 385 resolved cases, the 78.4% allowance rate is a stable and reliable figure. The 17.4% lift is a significant enough increase to justify the time and expense of an interview. Practitioners should be aware of the 1081-day median, which indicates a standard prosecution period. Using the 17.4% lift might help in navigating the 1081-day timeline more effectively. The data from 385 resolutions suggests that the examiner is open to discussion. Strategy should focus on leveraging the 17.4% lift to resolve any outstanding issues in Art Unit 3763.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18640036 | METHODS AND COMPOSITIONS FOR IONTOPHORETIC DRUG DELIVERY TO THE EYE | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18038902 | MEDICAL DEVICE INSUFFLATION ADAPTOR | Final Rejection | Intuitive Surgical Operations, Inc. |
| 18280870 | Drug Administration Management System and Operation Method Thereof | Non-Final OA | LG CHEM, LTD. |
| 18588048 | DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE | Non-Final OA | Eli Lilly and Company |
| 18705130 | METHOD OF INJECTING DIHYDROERGOTAMINE INTO THE BODY | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 18538927 | SUBCUTANEOUS INFUSION DEVICE | Non-Final OA | Becton, Dickinson and Company |
| 18238980 | CATHETER HAVING REINFORCEMENT FIBERS AND RELATED DEVICES AND METHODS | Non-Final OA | Becton, Dickinson and Company |
| 18135808 | Indicators for Instrument Advancement Device | Final Rejection | Becton, Dickinson and Company |
| 18114352 | Vascular Access Instrument | Non-Final OA | Becton, Dickinson and Company |
| 18460316 | Supplemental Device for Attachment to an Injection Device | Final Rejection | SANOFI-AVENTIS DEUTSCHLAND GMBH |
| 18559128 | A COMPONENT AND A SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY | Non-Final OA | SHL MEDICAL AG |
| 18285992 | DRUG DELIVERY DEVICE | Non-Final OA | medmix Switzerland AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy